Custom Search

Register
Sign In
Sign In Using Facebook

Osteoporosis Drug Raloxifene to Be Trialled in Schizophrenia Treatment

by Gopalan on  September 08, 2008 at 9:40 AM Drug News
  •   Print
  •   Share
  •   Comments
  •  Text 
 Osteoporosis Drug Raloxifene to Be Trialled in Schizophrenia Treatment
Australian researchers are to trial raloxifene, now used in osteoporosis and cancer, for schizophrenia treatment.

The three-year clinical drug trial follows the discovery that in schizophrenics a brain receptor that normally stimulates growth in adolescence is disabled.


Professor Cyndi Shannon Weickert, who holds Australia’s first Chair of Schizophrenia Research, said, “We now know that this brain receptor doesn’t work in the normal way for people with schizophrenia.

“With this drug trial, we can begin to stimulate it and try and get the neurodevelopmental program back on track.

For some patients we could see improvements in language and memory,” says Professor Shannon Weickert.

Her position is a joint initiative of UNSW, the Prince of Wales Medical Research Institute and the Schizophrenia Research Institute.

Her team’s findings are published in Human Molecular Genetics.

Researchers are recruiting 80 male and female patients with schizophrenia who will receive the new therapy in addition to their ongoing medication. The aim of the new trial is to learn how raloxifene can influence thought processing in schizophrenia and determine whether it could be used as a novel therapeutic treatment for cognitive problems in patients.

Raloxifene is a hormonal modulator that stimulates the oestrogen receptor in the brain. It does not simulate the oestrogen receptor in other parts of the body.

Raloxifene (brand name: Evista) is a drug that helps prevent and treat osteoporosis in postmenopausal women. Bone loss is common in postmenopausal women. Raloxifene works like the hormone estrogen to slow this bone loss and can even help increase normal bone growth.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Be the first to comment!
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  

X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
Quiz on Osteoporosis
Learn more about the debilitating disease of Osteoporosis by taking this quiz.
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Schizophrenia
Complete Medindia Resources
News Categories:  
Vision Health Center

Drug Related News

» Antidepressants and the Risk of Sudden Unexpected Death in Epilepsy » Research Says Financial Burden of Prescription Drugs is Dropping
» New Guidelines to Avoid Heparin Contamination » Weight Loss Drug Has Killed At Least 1,300 in France
» FDA Approves Sanofi’s Treatment for Head Lice » New Scoring Method may Help Decide Who Will Benefit From Stroke Drug
» New Guidelines Recommend Metformin to Treat Type 2 Diabetes » Novel Prostate Cancer Drug Target Identified
Read More >>